ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$270.56
−0.21%Margins
Gross margin
90.2%
EBITDA margin
7.4%
EBIT margin
10.4%
Net margin
71.7%
FCF margin
32.0%
52.6%
Return on equity
33.1%
Return on assets
5.8%
Return on invested capital
0.49x
Asset turnover
$408.4M
Cash from operations
$14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026